Cargando…
Characteristics and mid-term follow-up of COVID-19 patients with hematological diseases: a retrospective study from a French tertiary care hospital
Autores principales: | Vallet, Nicolas, Chevret, Sylvie, Feghoul, Linda, Aguinaga, Lorea, Bondeelle, Louise, Kaphan, Eleonore, Bertinchamp, Rémi, Soret, Juliette, Villesuzanne, Camille, De Castro, Nathalie, Sebert, Marie, Boutboul, David, Lengline, Etienne, Tudesq, Jean-Jacques, Rabian, Florence, Adès, Lionel, Xhaard, Alienor, Di Blasi, Roberta, Raffoux, Emmanuel, Galicier, Lionel, Le Goff, Jérôme, Delaugerre, Constance, Bergeron, Anne, Harel, Stéphanie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8279108/ https://www.ncbi.nlm.nih.gov/pubmed/34262018 http://dx.doi.org/10.1038/s41408-021-00512-5 |
Ejemplares similares
-
Benefits of dexamethasone on early outcomes in patients with acute myeloid leukemia with hyperleukocytosis: a propensity score matched analysis
por: Cerrano, Marco, et al.
Publicado: (2023) -
Post-remission outcomes in AML patients with high hyperleukocytosis and inaugural life-threatening complications
por: Fodil, Sofiane, et al.
Publicado: (2022) -
Acute Kidney Injury in Patients with Newly Diagnosed High-Grade Hematological Malignancies: Impact on Remission and Survival
por: Canet, Emmanuel, et al.
Publicado: (2013) -
Hepatosplenic Candidiasis in Patients With Hematological Malignancies: A 13-Year Retrospective Cohort Study
por: Boussen, Inès, et al.
Publicado: (2022) -
Complement C5 inhibition in patients with COVID- 19 - a promising target?
por: de Latour, Regis Peffault, et al.
Publicado: (2020)